These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22364303)

  • 1. C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.
    Eren F; Calay Z; Durak H; Eren B; Comunoğlu N; Aydin O
    Bosn J Basic Med Sci; 2012 Feb; 12(1):41-50. PubMed ID: 22364303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.
    Tavassoli FA
    Mod Pathol; 1998 Feb; 11(2):140-54. PubMed ID: 9504685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoexpression of c-erbB-2 in intraductal proliferative lesions of the female breast].
    Oliveira AB; De Luca LA; Carvalho GT; Arias VE; Carvalho LR; Assunção Mdo C
    Rev Assoc Med Bras (1992); 2004; 50(3):324-9. PubMed ID: 15499488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia.
    Bechert C; Kim JY; Tramm T; Tavassoli FA
    Virchows Arch; 2016 Dec; 469(6):659-667. PubMed ID: 27664050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast.
    Bratthauer GL; Tavassoli FA
    Virchows Arch; 2004 Apr; 444(4):340-4. PubMed ID: 14986131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphometric differentiation of intraductal proliferative breast lesions.
    Nagashima T; Suzuki M; Yagata H; Hashimoto H; Shishikura T; Imanaka N; Nakajima N
    Breast Cancer; 2000 Jan; 7(1):43-7. PubMed ID: 11029770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
    Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
    Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in presumptive precursor lesions of breast carcinomas.
    Aubele M; Werner M; Höfler H
    Anal Cell Pathol; 2002; 24(2-3):69-76. PubMed ID: 12446956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.